A R T I C L E S
Go¨ttker-Schnetmann et al.
1H NMR [400 MHz, 23 °C, acetone-d6, dynamic mixture of two
(656.21): C, 42.09; H, 6.45. Found: C, 41.90; H, 6.33. X-ray structure
analysis of compound 4a (-100 °C): space group and cell dimensions,
orthorhombic Pbcn, a 34.8215(7), b 10.49720(20), c 14.3434(3) Å,
volume 5242.92(18) Å3, empirical formula, C23H41O3P2IrCl. Cell
dimensions were obtained from 7667 reflections with 2θ angle in the
range 5.00-56.00°. Crystal dimensions: 0.35 × 0.15 × 0.05 mm, FW
isomers, second isomer in {}]: δ 8.54 (s, 1H, OH), 8.14 {8.14} (s,
4
2H, 2′- and 6′-H), 7.98 {7.98} (s, 1H, 4′-H), 6.73 {6.71} (d, JH-H
)
4
2.1 Hz, 2H, 4- and 6-H), 6.49 {3.92} (t, JH-H ) 2.1 Hz, 1H, 2-H {s,
2H, 2-H2}). 1H NMR (300 MHz, 23 °C, CDCl3, only dihydroxy
form): δ 7.96 (s, 2H, 4′- and 6′-H), 7.86 (s, 1H, 2′-H), 6.67 (s, 2H, 4-
and 6-H), 6.45 (s, 1H, 2-H), 5.56 (s, 2H, 2 × OH). 19F{1H} NMR
(376.5 MHz, 23 °C, acetone-d6): δ -63.72. 13C{1H} NMR [100.6 MHz,
23 °C, acetone-d6, second isomer in {}]: δ 160.1 {160.2 and 210.2}
(Cq, C1 and C3), 144.6 and 140.7 {144.6 and 140.7} (Cq each, C5 and
) 655.19, Z ) 8, F(000) ) 2611.51, Fcalc 1.660 Mg/m3, µ 5.35 mm-1
,
λ 0.71073 Å, 2θ (max) 56.0°. The intensity data were collected on a
Bruker SMART 1K diffractometer, using the ω scan mode. The h,k,l
ranges used during structure solution and refinement are Hmin,max 0,
46; Kmin,max 0, 13; Lmin,max 0, 18. No. of reflections measured 25 346,
no. of unique reflections 6337, no. of reflections with Inet > 2.5σ (Inet)
4687. Merging R-value on intensities 0.041. Correction was made for
absorption using SADABS. Details of the last least squares cycle: 71
atoms, 272 parameters full-matrix on Fo counter wts (k 0.000050). The
residuals are as follows: significant reflections, 4682 RF 0.036, RW 0.037;
all reflections, 6337 RF 0.058, RW 0.041; included reflections, 4682 RF
2
C1′), 132.5 {132.5} (Cq, q, JF-C ) 33.1 Hz, C3′ and C5′), 128.1
{128.1} (CH, m br, C2′ and C6′), 124.5 {124.5} (Cq, q, 1JF-C ) 272.1
Hz, 3′- and 5′-CF3), 121.6 (CH, m, C4′), 106.7 {106.8 and 104.1} (CH,
C4 and C6), 104.0 {69.5 br} (CH {CH2}, C2).
5-ArFPCP (5f). From 322 mg (1 mmol) of 5-[3,5-bis(trifluoro-
methyl)phenyl]resorcinol (6f), 53 mg (2.1 mmol) of NaH, and 395 mg
(2.1 mmol) of di-tert-butyl-chlorophosphine was obtained 550 mg (0.90
mmol, 90%) of 5-(ArF)PCP (5f) as a colorless oil.
0.036, RW 0.037; GOF 1.6181, where RF ) ∑(Fo - Fc)/∑(Fo), RW
)
[∑(w(Fo - Fc)2)/∑(wFo )]1/2 and GOF ) [∑(w(Fo - Fc)2)/(no. of reflns
- no. of params.)]1/2. The maximum shift/sigma ratio was 0.000. Last
D-map: minimum density -2.540 e/Å3, maximum density 1.440 e/Å3.
Secondary ext. coeff. 0.2050 µm sigma 0.0463.
2
p-MePCPIrHCl (4b). Using the general procedure, we heated 168
mg (0.25 mmol) of [(COD)IrCl]2 and 227 mg (0.55 mmol) of 5-MePCP
(5b) for 12 h at 150 °C in 3 mL of toluene to yield 279 mg (0.44
mmol, 87%) of compound 4b as a red brown microcrystalline solid
1H NMR (300 MHz, 23 °C, C6D6): δ 7.78 (s, 2H, 2′- and 6′-H),
7.65 (s, 1H, 4′-H), 7.17 (s, 2H, 4- and 6-H), 7.08 (s, 1H, 2-H), 1.13 [d,
3JP-H ) 12.0 Hz, 2 × P(tBu)2]. 31P{1H} NMR (121.5 MHz, 23 °C,
C6D6): δ 154.8. 19F{1H} NMR (376.5 MHz, 23 °C, CDCl3): δ -62.82.
13C{1H} NMR (75.5 MHz, 23 °C, C6D6): δ 162.1 (Cq, d, 2JP-C ) 10.2
Hz, C1 and C3), 143.8 and 140.9 (Cq each, C5 and C1′), 132.1 (Cq, q,
2JF-C ) 33.1 Hz, C3′ and C5′), 127.7 (CH, C2′ and C6′), 123.8 (Cq, q,
1JF-C ) 272.7 Hz, 3′- and 5′-CF3), 121.1 (CH, m, C4′), 111.1 (CH, d,
3JP-C ) 9.5 Hz, C4 and C6), 108.8 (CH, t, 3JP-C ) 14.1 Hz, C2), 35.8
[Cq, d, 1JP-C ) 26.7 Hz, 2 × P(tBu)2], 27.4 [CH3, d, 2JP-C ) 15.7 Hz,
2 × P(tBu)2].
1
slightly soluble in pentane. H NMR (400 MHz, 23 °C, CD2Cl2): δ
6.42 (s, 2H, 3- and 5-H), 2.26 (s, 3H, 4-CH3), 1.35 (m, 36H, 4 × tBu),
2
-41.63 (t, JP-H ) 13.1 Hz, 1H, IrH). 31P{1H} NMR (162 MHz, 23
°C, CD2Cl2): δ 176.1. 13C{1H} NMR (100.6 MHz, 23 °C, CD2Cl2): δ
1167.6 (Cq, vt, JP-C ) 5.9 Hz, C2 and C6), 136.3 (Cq, C4), 114.4 (Cq,
m br, C1), 106.0 (CH, vt, JP-C ) 5.3 Hz, C3 and C5), 43.3 and 39.7
[Cq each, vt each, JP-C ) 11.5 and 12.7 Hz, 2 × P(tBu)2], 27.8 and
27.6 [CH3 each, vt each, JP-C ) 3.1 and 3.1 Hz, 2 × P(tBu)2], 21.5
(4-CH3). IR (CH2Cl2, cm-1): 2945, 2904, 2871, 1596, 1557, 1475, 1392.
Elemental analysis calcd for C23H42O2P2ClIr (640.21): C, 43.15; H,
6.61. Found: C, 43.89; H, 6.70.
General Procedure for the Synthesis of Complexes p-XPCPIrHCl
(4a-f). A rubber septum-capped Schlenk flask was charged with 0.5
equiv of [(COD)IrCl]2 and 1.1 equiv of the respective 5-XPCP ligand
(5a-f). The flask was evacuated and refilled with argon. A small
amount of toluene was added via syringe, and the solution was stirred
in an oil bath for 1-16 h at 150 °C while the products 4a-d started
to precipitate. The reaction mixture was rapidly cooled to 30 °C. The
solvent and free (1,3)-COD were removed in a vacuum (10-3 mbar,
30 °C), and the residue was extracted with a small amount of pentane
under ultrasound (10 min). After filtration (no inert gas required), the
solid was washed with small amounts of pentane and dried under high
vacuum (10-3 mbar) to yield analytically pure samples. For higher
solubility, it is desirable to obtain the products as microcrystalline solids
when used for further transformations. In the case of compounds 4e,f,
the remaining mother liquors were flash chromatographed on neutral
alumina to yield an additional crop of compounds 4e,f.
p-HPCPIrHCl (4c). Using the general procedure, we heated 336
mg (0.5 mmol) of [(COD)IrCl]2 and 438 mg (1.1 mmol) of 5-HPCP
(5c) for 12 h at 150 °C in 3 mL of toluene to yield 585 mg (0.93
mmol, 93%) of compound 4c as a red brown microcrystalline solid
virtually insoluble in pentane. 1H NMR (400 MHz, 23 °C, CD2Cl2): δ
6.76 (t, 3JH-H ) 8.0 Hz, 1H, 4-H), 6.54 (d, 3JH-H ) 8.0 Hz, 2H, 3- and
2
5-H), 1.35 (m, 36H, 4 × tBu), -41.39 (t, JP-H ) 13.1 Hz, 1H, IrH).
31P{1H} NMR (162 MHz, 23 °C, CD2Cl2): δ 175.8. 13C{1H} NMR
(100.6 MHz, 23 °C, CD2Cl2): δ 167.7 (Cq, vt, JP-C ) 5.9 Hz, C2 and
C6), 125.7 (CH, C4), 118.5 (Cq, m br, C1), 105.0 (CH, C3 and C5),
43.3 and 39.7 [Cq, each, vt each, JP-C ) 11.5 and 12.7 Hz, 2 × P(tBu)2],
27.8 and 27.6 [CH3 each, vt each, JP-C ) 3.1 and 3.1 Hz, 2 × P(tBu)2].
IR (CH2Cl2, cm-1): 2945, 2904, 2871, 1579, 1562, 1475, 1371.
Elemental analysis calcd for C22H40O2P2ClIr (626.18): C, 42.19; H,
6.44. Found: C, 42.40; H, 6.42.
p-MeOPCPIrHCl (4a). Using the general procedure, we heated 168
mg (0.25 mmol) of [(COD)IrCl]2 and 236 mg (0.55 mmol) of
5-MeOPCP (5a) for 16 h at 150 °C in 3 mL of toluene to yield 293
mg (0.45 mmol, 89%) of compound 4a as a dark red microcrystalline
solid that is virtually insoluble in pentane. 1H NMR (300 MHz, 23 °C,
CDCl3): δ 6.27 (s, 2H, 3- and 5-H), 3.78 (s, 3H, OCH3), 1.37 [m,
p-FPCPIrHCl (4d). Using the general procedure, we heated 168
mg (0.25 mmol) of [(COD)IrCl]2 and 229 mg (0.55 mmol) of 5-FPCP
(5d) for 8 h at 150 °C in 3 mL of toluene to yield 300 mg (0.47 mmol,
93%) of compound 4d as a red brown microcrystalline solid virtually
insoluble in pentane. 1H NMR (400 MHz, 23 °C, CD2Cl2): δ 6.37 (d,
3JF-H ) 9.5 Hz, 2H, 3- and 5-H), 1.34 (m, 36H, 4 × tBu), -41.61 (t,
2JP-H ) 13.1 Hz, 1H, IrH). 31P{1H} NMR (162 MHz, 23 °C, CD2Cl2):
2
36H, 2 × P(tBu)2], -41.87 (t, JP-H ) 13.2 Hz, IrH). 31P{1H} NMR
(121.5 MHz, 23 °C, CDCl3): δ 177.6. 13C{1H} NMR (75.5 MHz, 23
°C, CDCl3): δ 167.3 (Cq, vt, JP-C ) 6.0 Hz, C2 and C6), 159.6 (Cq,
δ 179.1. 19F{1H} NMR (376.5 MHz, 23 °C, CD2Cl2): δ -119.01. 13C-
3
{1H} NMR (75.5 MHz, 23 °C, CD2Cl2): δ 167.0 (Cq, dvt, JF-C
)
C4), 108.1 (Cq, m br, C1), 91.9 (CH, t, JP-C ) 5.1 Hz, C3 and C5),
14.8 Hz, JP-C ) 5.8 Hz, C2 and C6), 162.7 (Cq, d, 1JF-C ) 237.0 Hz,
C4), 112.5 (Cq, m br, C1), 93.4 (CH, dvt, 2JF-C ) 26.0 Hz, JP-C ) 5.6
Hz, C3 and C5), 43.4 and 39.8 [Cq each, vt each, JP-C ) 11.3 and 12.5
Hz, 2 × P(tBu)2], 27.7 and 27.6 [CH3 each, vt each, JP-C ) 3.1 and
3.1 Hz, 2 × P(tBu)2]. IR (CH2Cl2, cm-1): 2946, 2904, 2871, 1594,
2
55.4 (OCH3), 43.0 and 39.5 [Cq each, vt each, JP-C ) 22.6 and 25.3
Hz, 2 × P(tBu)2], 27.7 and 27.5 [CH3, each vt, each, JP-C ) 3.2 and
3.1 Hz, 2 × P(tBu)2]. IR (CH2Cl2, cm-1): 2944, 2904, 2871, 1595,
1563, 1475, 1370. Elemental analysis calcd for C23H42O3P2ClIr
9
1810 J. AM. CHEM. SOC. VOL. 126, NO. 6, 2004